Over the last two decades, psychedelic clinical trials have delivered promising results relative to their potential mental health benefits. However, clinical trials are still in the early stages, meaning the world has a lot more to learn about these complex substances. Fortunately, we’re keeping track of psychedelic research as it evolves so we can bring you the latest evidence-based insights. We’re also monitoring the latest regulatory developments and hot topics so you can impress your friends with mind-blowing psychedelic conversation starters. Here we review the top psychedelics news stories, research findings, and legal milestones you need to know for April 2022.
New Study Explores Psychedelics and Consciousness
Researchers from Johns Hopkins Medicine analyzed the link between psychedelic experiences and shifts in consciousness perspectives. The study surveyed over 1,600 participants (mostly white, primarily Caucasian Americans) that had belief-changing experiences through classic psychedelics, such as LSD, psilocybin mushrooms, and ayahuasca. Ultimately, the Johns Hopkins team discovered that those who reported higher ratings of mystical experiences also developed the perspective that inanimate and animate objects had higher levels of consciousness. After the event, participants began to assign consciousness to insects, fungi, plants, and inanimate natural objects. Sandeep Nayak, M.D., one of the researchers at Johns Hopkins University’s Center for Psychedelic and Consciousness Research, stated the increase of consciousness associated with psychedelic use may be related to “intrinsic drug impact, cultural variables, or whether psychedelics can somehow uncover innate cognitive biases that attach mental qualities to the world.”
Oregon’s Proposed Psilocybin Rules
In November 2020, Oregon became the first state to approve psilocybin for therapeutic and medical use via Oregon Ballot Measure 109 (M109). Now legislators are working to ensure implementation runs smoothly while setting a well-established precedent for other states to follow. As a result, the Oregon Psilocybin Services (OPS) of the Oregon Health Authority proposed rules requiring legal psilocybin to be all-natural, organic, and GMO-free. OPS then invited the public for an open floor discussion on April 18th and 22nd to share their perspectives and review the proposed plans. Allowing public opinion, concerns, and suggestions is a mindful choice that ensures experienced psilocybin advocates have a chance to make their informed voices heard.